Jensen Michael P, Lange Steven J, Mehn Mark P, Que Emily L, Que Lawrence
Department of Chemistry and Center for Metals in Biocatalysis, University of Minnesota, Minneapolis, Minnesota 55455, USA.
J Am Chem Soc. 2003 Feb 26;125(8):2113-28. doi: 10.1021/ja028478l.
Many nonheme iron-dependent enzymes activate dioxygen to catalyze hydroxylations of arene substrates. Key features of this chemistry have been developed from complexes of a family of tetradentate tripodal ligands obtained by modification of tris(2-pyridylmethyl)amine (TPA) with single alpha-arene substituents. These included the following: -C(6)H(5) (i.e., 6-PhTPA), L(1); -o-C(6)H(4)D, o-d(1)-L(1); -C(6)D(5), d(5)-L(1); -m-C(6)H(4)NO(2), L(2); -m-C(6)H(4)CF(3), L(3); -m-C(6)H(4)Cl, L(4); -m-C(6)H(4)CH(3), L(5); -m-C(6)H(4)OCH(3), L(6); -p-C(6)H(4)OCH(3), L(7). Additionally, the corresponding ligand with one alpha-phenyl and two alpha-methyl substituents (6,6-Me(2)-6-PhTPA, L(8)) was also synthesized. Complexes of the formulas (L(1))Fe(II)(NCCH(3))(2)(2), [(L(n)())Fe(II)(OTf)(2)] (n = 1-7, OTf = (-)O(3)SCF(3)), and (L(8))Fe(II)(OTf)(2) were obtained and characterized by (1)H NMR and UV-visible spectroscopies and by X-ray diffraction in the cases of (L(1))Fe(II)(NCCH(3))(2)(2), [(L(6))Fe(II)(OTf)(2)], and (L(8))Fe(II)(OTf)(2). The complexes react with tert-butyl hydroperoxide ((t)()BuOOH) in CH(3)CN solutions to give iron(III) complexes of ortho-hydroxylated ligands. The product complex derived from L(1) was identified as the solvated monomeric complex (L(1)O(-))Fe(III) in equilibrium with its oxo-bridged dimer (L(1)O(-))(2)Fe(III)(2)(mu(2)-O), which was characterized by X-ray crystallography as the BPh(4)(-) salt. The L(8) product was also an oxo-bridged dimer, (L(8)O(-))(2)Fe(III)(2)(mu(2)-O). Transient intermediates were observed at low temperature by UV-visible spectroscopy, and these were characterized as iron(III) alkylperoxo complexes by resonance Raman and EPR spectroscopies for L(1) and L(8). [(L(1))Fe(II)(OTf)(2)] gave rise to a mixture of high-spin (S = 5/2) and low-spin (S = 1/2) Fe(III)-OOR isomers in acetonitrile, whereas both [(L(1))Fe(OTf)(2)] in CH(2)Cl(2) and (L(8))Fe(OTf)(2) in acetonitrile afforded only high-spin intermediates. The L(1) and L(8) intermediates both decomposed to form respective phenolate complexes, but their reaction times differed by 3 orders of magnitude. In the case of L(1), (18)O isotope labeling indicated that the phenolate oxygen is derived from the terminal peroxide oxygen via a species that can undergo partial exchange with exogenous water. The iron(III) alkylperoxo intermediate is proposed to undergo homolytic O-O bond cleavage to yield an oxoiron(IV) species as an unobserved reactive intermediate in the hydroxylation of the pendant alpha-aryl substituents. The putative homolytic chemistry was confirmed by using 2-methyl-1-phenyl-2-propyl hydroperoxide (MPPH) as a probe, and the products obtained in the presence and in the absence of air were consistent with formation of alkoxy radical (RO(*)). Moreover, when one ortho position was labeled with deuterium, no selectivity was observed between hydroxylation of the deuterated and normal isotopomeric ortho sites, but a significant 1,2-deuterium shift ("NIH shift") occurred. These results provide strong mechanistic evidence for a metal-centered electrophilic oxidant, presumably an oxoiron(IV) complex, in these arene hydroxylations and support participation of such a species in the mechanisms of the nonheme iron- and pterin-dependent aryl amino acid hydroxylases.
许多非血红素铁依赖性酶激活双氧以催化芳烃底物的羟基化反应。这种化学性质的关键特征是由一类四齿三脚架配体的配合物发展而来的,这些配体是通过用单个α-芳烃取代基修饰三(2-吡啶甲基)胺(TPA)得到的。其中包括:-C(6)H(5)(即6-PhTPA),L(1);-o-C(6)H(4)D,o-d(1)-L(1);-C(6)D(5),d(5)-L(1);-m-C(6)H(4)NO(2),L(2);-m-C(6)H(4)CF(3),L(3);-m-C(6)H(4)Cl,L(4);-m-C(6)H(4)CH(3),L(5);-m-C(6)H(4)OCH(3),L(6);-p-C(6)H(4)OCH(3),L(7)。此外,还合成了具有一个α-苯基和两个α-甲基取代基的相应配体(6,6-Me(2)-6-PhTPA,L(8))。得到了化学式为(L(1))Fe(II)(NCCH(3))(2)(2)、[(L(n))Fe(II)(OTf)(2)](n = 1 - 7,OTf = (-)O(3)SCF(3))和(L(8))Fe(II)(OTf)(2)的配合物,并通过(1)H NMR和紫外可见光谱进行了表征,对于(L(1))Fe(II)(NCCH(3))(2)(2)、[(L(6))Fe(II)(OTf)(2)]和(L(8))Fe(II)(OTf)(2),还通过X射线衍射进行了表征。这些配合物在CH(3)CN溶液中与叔丁基过氧化氢((t)BuOOH)反应,生成邻位羟基化配体的铁(III)配合物。源自L(1)的产物配合物被鉴定为溶剂化单体配合物(L(1)O(-))Fe(III),它与其氧桥联二聚体(L(1)O(-))(2)Fe(III)(2)(μ(2)-O)处于平衡状态,通过X射线晶体学将其表征为BPh(4)(-)盐。L(8)产物也是一个氧桥联二聚体,(L(8)O(-))(2)Fe(III)(2)(μ(2)-O)。通过紫外可见光谱在低温下观察到了瞬态中间体,通过共振拉曼光谱和EPR光谱对L(1)和L(8)的这些中间体进行表征,表明它们是铁(III)烷基过氧配合物。[(L(1))Fe(II)(OTf)(2)]在乙腈中产生高自旋(S = 5/2)和低自旋(S = 1/2)的Fe(III)-OOR异构体混合物,而[(L(1))Fe(OTf)(2)]在CH(2)Cl(2)中以及(L(8))Fe(OTf)(2)在乙腈中仅产生高自旋中间体。L(1)和L(8)中间体都分解形成各自的酚盐配合物,但它们的反应时间相差3个数量级。在L(1)的情况下,(18)O同位素标记表明酚盐氧源自末端过氧化物氧,通过一个可以与外源水进行部分交换的物种。提出铁(III)烷基过氧中间体经历均裂O - O键断裂,生成一个氧铁(IV)物种,作为侧链α-芳基取代基羟基化反应中未观察到的反应中间体。通过使用2-甲基-1-苯基-2-丙基过氧化氢(MPPH)作为探针证实了假定的均裂化学,在有空气和无空气存在下得到的产物与烷氧基自由基(RO(*))的形成一致。此外,当一个邻位用氘标记时,在氘代和正常同位素异构体邻位的羟基化之间未观察到选择性,但发生了显著的1,2-氘迁移(“NIH迁移”)。这些结果为这些芳烃羟基化反应中以金属为中心的亲电氧化剂(可能是一个氧铁(IV)配合物)提供了有力的机理证据,并支持这种物种参与非血红素铁和蝶呤依赖性芳基氨基酸羟化酶的机制。